CEFTIZOXIME IN THE TREATMENT OF INFECTIONS IN PATIENTS WITH CANCER

被引：8
作者：
FAINSTEIN, V
BOLIVAR, R
ELTING, L
VALDIVIESO, M
BODEY, GP
机构：
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1982年 / 10卷
关键词：
D O I：
10.1093/jac/10.suppl_C.167
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：167 / 173
页数：7
相关论文
共 11 条
[1]   COMPARATIVE INVITRO STUDY OF NEW CEPHALOSPORINS [J].
BODEY, GP ;
FAINSTEIN, V ;
HINKLE, AM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 20 (02) :226-230
[2]  
BODY GP, 1981, CURRENT THERAPEUTIC, V29, P294
[3]   CAUSES OF DEATH IN ADULTS WITH ACUTE-LEUKEMIA [J].
CHANG, HY ;
RODRIGUEZ, V ;
NARBONI, G ;
BODEY, GP ;
LUNA, MA ;
FREIREICH, EJ .
MEDICINE, 1976, 55 (03) :259-268
[4]   ANTI-BACTERIAL ACTIVITY OF CEFTIZOXIME, A BETA-LACTAMASE-STABLE CEPHALOSPORIN [J].
FU, KP ;
NEU, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (04) :583-590
[5]   COMPARATIVE INVITRO ACTIVITIES OF CEFOTAXIME AND CEFTIZOXIME (FK749) - NEW CEPHALOSPORINS WITH EXCEPTIONAL POTENCY [J].
GREENWOOD, D ;
PEARSON, N ;
ELEY, A ;
OGRADY, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (03) :397-401
[6]  
GROVE DA, 1967, LABORATORY MANUAL, P188
[7]  
INAGAKI J, 1974, CANCER-AM CANCER SOC, V33, P568, DOI 10.1002/1097-0142(197402)33:2<568::AID-CNCR2820330236>3.0.CO
[8]  
2-2
[9]   ANTIBACTERIAL ACTIVITY OF CEFTIZOXIME (FK 749), A NEW CEPHALOSPORIN, AGAINST CEPHALOSPORIN-RESISTANT BACTERIA, AND ITS STABILITY TO BETA-LACTAMASE [J].
KOJO, H ;
NISHIDA, M ;
GOTO, S ;
KUWAHARA, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (05) :549-553
[10]  
RYAN RW, 1982, ANN CLIN LAB SCI, V12, P32
12